Position in ALVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,137
+$978 QoQ
Shares Held
5,288
+58.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Tower Research Capital LLC (TRC) holds $6,284,154 across 59 Drug Manufacturers - Specialty & Generic names. ALVO ranks #37 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,684 | $998,578 | |
| 2 | ALKS |
Alkermes plc.
|
16,120 | $570,003 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
4,070 | $536,181 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
19,404 | $464,337 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
6,000 | $455,100 | |
| 6 | ZTS |
Zoetis Inc.
|
3,469 | $410,069 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
16,717 | $347,044 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
23,887 | $227,404 |
All Filings in ALVO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,137 | 5,288 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,159 | 3,345 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $50,581 | 6,176 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,446 | 1,913 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $80,522 | 8,327 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,713 | 961 | Shares | Other | 2025-02-13 | |
| 2022-09-30 | $6,780 | 1,003 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $20,418 | 2,487 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||